The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Polushkina T.V.

Lomonosov Moscow State University;
I.V. Davydovsky City clinical Hospital

Sotnikova T.N.

I.V. Davydovsky City Clinical Hospital

Danilova N.V.

Lomonosov Moscow State University

Prognostic significance and comparison of methods for calculating tumor budding in gastric cancer

Authors:

Polushkina T.V., Sotnikova T.N., Danilova N.V.

More about the authors

Read: 630 times


To cite this article:

Polushkina TV, Sotnikova TN, Danilova NV. Prognostic significance and comparison of methods for calculating tumor budding in gastric cancer. Russian Journal of Archive of Pathology. 2025;87(3):17‑25. (In Russ.)
https://doi.org/10.17116/patol20258703117

Recommended articles:
Claudin-18.2 and gastric cancer: from physiology to carcinogenesis. Russian Journal of Archive of Pathology. 2024;(6):92-99
The phenomenon of tumor budding in gastric cancer. Russian Journal of Archive of Pathology. 2025;(2):79-87
A clinical case of successful treatment of stage IV gastric cancer. P.A. Herzen Journal of Onco­logy. 2024;(5):54-58
Pancreaticoduodenectomy combined with multivisceral rese­ctions. Piro­gov Russian Journal of Surgery. 2024;(11):77-83
Gastric cancer: inci­dence, risk factors, screening. Russian Journal of Preventive Medi­cine. 2024;(12):135-139

References:

  1. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229-263.  https://doi.org/10.3322/caac.21834
  2. Díaz Del Arco C, Ortega Medina L, Estrada Muñoz L, García Gómez de Las Heras S, Fernández Aceñero MJ. Is there still a place for conventional histopathology in the age of molecular medicine? Laurén classification, inflammatory infiltration and other current topics in gastric cancer diagnosis and prognosis. Histol Histopathol. 2021;36(6):587-613.  https://doi.org/10.14670/HH-18-309
  3. Imai T. The growth of human carcinoma: a morphological analysis. Fukuoka Igaku Zasshi. 1954;45:72-102. 
  4. Lugli A, Kirsch R, Ajioka Y, Bosman F, Cathomas G, Dawson H, El Zimaity H, Fléjou JF, Hansen TP, Hartmann A, et al. Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016. Mod Pathol. 2017;30(9):1299-1311. https://doi.org/10.1038/modpathol.2017.46
  5. Ueno H, Mochizuki H, Hashiguchi Y, Shimazaki H, Aida S, Hase K, Matsukuma S, Kanai T, Kurihara H, Ozawa K, et al. Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology. 2004;127(2):385-394.  https://doi.org/10.1053/j.gastro.2004.04.022
  6. Karamitopoulou E, Zlobec I, Born D, Kondi-Pafiti A, Lykoudis P, Mellou A, Gennatas K, Gloor B, Lugli A. Tumour budding is a strong and independent prognostic factor in pancreatic cancer. Eur J Cancer. 2013;49(5):1032-1039. https://doi.org/10.1016/j.ejca.2012.10.022
  7. Wang LM, Kevans D, Mulcahy H, O’Sullivan J, Fennelly D, Hyland J, O’Donoghue D, Sheahan K. Tumor budding is a strong and reproducible prognostic marker in T3N0 colorectal cancer. Am J Surg Pathol. 2009;33(1):134-141.  https://doi.org/10.1097/PAS.0b013e318184cd55
  8. Qi B, Liu L, Pan Y, Xu S, Li J. Prognostic significance of peritumoural and intratumoural budding in intestinal-type gastric adenocarcinoma. Arab J Gastroenterol. 2020;21(2):111-116.  https://doi.org/10.1016/j.ajg.2020.04.005
  9. Che K, Zhao Y, Qu X, Pang Z, Ni Y, Zhang T, Du J, Shen H. Prognostic significance of tumor budding and single cell invasion in gastric adenocarcinoma. Onco Targets Ther. 2017;10:1039-1047. https://doi.org/10.2147/OTT.S127762
  10. Olsen S, Jin L, Fields RC, Yan Y, Nalbantoglu I. Tumor budding in intestinal-type gastric adenocarcinoma is associated with nodal metastasis and recurrence. Hum Pathol. 2017;68:26-33.  https://doi.org/10.1016/j.humpath.2017.03.021
  11. Gulluoglu M, Yegen G, Ozluk Y, Keskin M, Dogan S, Gundogdu G, Onder S, Balik E. Tumor budding is independently predictive for lymph node involvement in early gastric cancer. Int J Surg Pathol. 2015;23(5):349-358.  https://doi.org/10.1177/1066896915581200
  12. Puppa G, Senore C, Sheahan K, Vieth M, Lugli A, Zlobec I, Pecori S, Wang LM, Langner C, Mitomi H, et al. Diagnostic reproducibility of tumour budding in colorectal cancer: a multicentre, multinational study using virtual microscopy. Histopathology. 2012;61(4):562-575.  https://doi.org/10.1111/j.1365-2559.2012.04270.x
  13. Guo YX, Zhang ZZ, Zhao G, Zhao EH. Prognostic and pathological impact of tumor budding in gastric cancer: a systematic review and meta-analysis. World J Gastrointest Oncol. 2019;11(10):898-908.  https://doi.org/10.4251/wjgo.v11.i10.898
  14. Ulase D, Heckl S, Behrens HM, Krüger S, Röcken C. Prognostic significance of tumour budding assessed in gastric carcinoma according to the criteria of the International Tumour Budding Consensus Conference. Histopathology. 2020;76(3):433-446.  https://doi.org/10.1111/his.13997
  15. Szalai L, Jakab Á, Kocsmár I, Szirtes I, Kenessey I, Szijártó A, Schaff Z, Kiss A, Lotz G, Kocsmár É. Prognostic ability of tumor budding outperforms poorly differentiated clusters in gastric cancer. Cancers (Basel). 2022;14(19):4731. https://doi.org/10.3390/cancers14194731

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.